Ocugen Management
Management criteria checks 2/4
Ocugen's CEO is Shankar Musunuri, appointed in Sep 2019, has a tenure of 4.42 years. total yearly compensation is $7.66M, comprised of 9.3% salary and 90.7% bonuses, including company stock and options. directly owns 0.8% of the company’s shares, worth €1.88M. The average tenure of the management team and the board of directors is 1.4 years and 4.3 years respectively.
Key information
Shankar Musunuri
Chief executive officer
US$7.7m
Total compensation
CEO salary percentage | 9.3% |
CEO tenure | 4.4yrs |
CEO ownership | 0.8% |
Management average tenure | 1.4yrs |
Board average tenure | 4.3yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Sep 30 2023 | n/a | n/a | -US$76m |
Jun 30 2023 | n/a | n/a | -US$83m |
Mar 31 2023 | n/a | n/a | -US$80m |
Dec 31 2022 | US$8m | US$715k | -US$81m |
Sep 30 2022 | n/a | n/a | -US$74m |
Jun 30 2022 | n/a | n/a | -US$63m |
Mar 31 2022 | n/a | n/a | -US$69m |
Dec 31 2021 | US$8m | US$541k | -US$58m |
Sep 30 2021 | n/a | n/a | -US$48m |
Jun 30 2021 | n/a | n/a | -US$47m |
Mar 31 2021 | n/a | n/a | -US$38m |
Dec 31 2020 | US$2m | US$500k | -US$34m |
Jun 30 2020 | n/a | n/a | -US$30m |
Mar 31 2020 | n/a | n/a | -US$18m |
Dec 31 2019 | US$572k | US$420k | -US$20m |
Sep 30 2019 | n/a | n/a | -US$39m |
Jun 30 2019 | n/a | n/a | -US$18m |
Mar 31 2019 | n/a | n/a | -US$19m |
Dec 31 2018 | US$431k | US$420k | -US$18m |
Compensation vs Market: Shankar's total compensation ($USD7.66M) is above average for companies of similar size in the BG market ($USD566.05K).
Compensation vs Earnings: Shankar's compensation has been consistent with company performance over the past year.
CEO
Shankar Musunuri (59 yo)
4.4yrs
Tenure
US$7,662,810
Compensation
Dr. Shankar Musunuri, Ph D., MBA, is the Co-Founder of Ocugen, Inc. and has been its Chairman and Chief Executive Officer and Director since September 27, 2019. He served as Interim Principal Financial Off...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Co-Founder | 4.4yrs | US$7.66m | 0.80% $ 1.9m | |
Co-founder & Independent Director | no data | US$341.82k | 0.27% $ 643.6k | |
Interim Chief Accounting Officer & Principal Financial Officer and Corporate Controller | less than a year | no data | no data | |
Chief Scientific Officer and Head of Research & Development | 1.4yrs | no data | 0.041% $ 95.4k | |
General Counsel | no data | no data | no data | |
Head of Corporate Communications | no data | no data | no data | |
Senior Vice President of Commercial | 2.7yrs | no data | no data | |
Head of Regulatory & Quality | less than a year | no data | no data |
1.4yrs
Average Tenure
48.5yo
Average Age
Experienced Management: 2H51's management team is not considered experienced ( 1.4 years average tenure), which suggests a new team.
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Co-Founder | 4.4yrs | US$7.66m | 0.80% $ 1.9m | |
Co-founder & Independent Director | 4.4yrs | US$341.82k | 0.27% $ 643.6k | |
Independent Director | 3.8yrs | US$357.60k | 0% $ 0 | |
Member of Retina Scientific Advisory Board | 4.3yrs | no data | no data | |
Independent Director | 4.4yrs | US$347.28k | 0% $ 0 | |
Member of Retina Scientific Advisory Board | no data | no data | no data | |
Vaccine Scientific Advisory Board Member | 3.2yrs | no data | no data | |
Independent Director | 4.4yrs | US$335.56k | 0.45% $ 1.1m | |
Member of Retina Scientific Advisory Board | no data | no data | no data | |
Independent Director | 3.8yrs | US$348.18k | 0.019% $ 45.6k | |
Vaccine Scientific Advisory Board Member | 3.2yrs | no data | no data | |
Member of Retina Scientific Advisory Board | 4.3yrs | no data | no data |
4.3yrs
Average Tenure
59yo
Average Age
Experienced Board: 2H51's board of directors are considered experienced (4.3 years average tenure).